comparemela.com
  1. Home
  2. Live Updates
  3. Krishna Vaddi - Breaking News

Latest Breaking News On - Krishna vaddi - Page 1 : comparemela.com

Prelude Therapeutics Incorporated (NASDAQ:PRLD) is definitely on the radar of hedge funds investors who own 33% of the company

Key Insights Given the large stake in the stock by institutions, Prelude Therapeutics' stock price might be vulnerable.

Krishna vaddiPrelude therapeutics incorporatedPrelude therapeuticPrelude therapeuticsNstitutional ownershipInstitutional investorsHedge fundsPrelude therapeutics

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.